3016 — Episil-Precision Income Statement
0.000.00%
Last trade - 00:00
- TWD16.91bn
- TWD15.62bn
- TWD4.24bn
- 62
- 11
- 83
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,855 | 4,039 | 5,043 | 5,900 | 4,237 |
Cost of Revenue | |||||
Gross Profit | 245 | 244 | 726 | 1,102 | 495 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 3,848 | 4,028 | 4,579 | 5,115 | 4,054 |
Operating Profit | 6.4 | 11.5 | 464 | 785 | 183 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.5 | 19.9 | 481 | 855 | 206 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.5 | 25.7 | 381 | 681 | 164 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.5 | 25.7 | 381 | 681 | 164 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 10.5 | 25.7 | 381 | 686 | 164 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.038 | 0.069 | 1.35 | 2.36 | 0.563 |
Dividends per Share |